AlphaQuest LLC Has $571,000 Stock Holdings in Mesa Laboratories, Inc. $MLAB

AlphaQuest LLC raised its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 9,667.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,056 shares of the medical instruments supplier’s stock after buying an additional 5,994 shares during the period. AlphaQuest LLC owned about 0.11% of Mesa Laboratories worth $571,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Select Equity Group L.P. lifted its position in Mesa Laboratories by 439.0% in the 1st quarter. Select Equity Group L.P. now owns 73,897 shares of the medical instruments supplier’s stock valued at $8,769,000 after acquiring an additional 60,186 shares in the last quarter. Nuveen LLC purchased a new stake in shares of Mesa Laboratories in the first quarter worth approximately $2,305,000. Raymond James Financial Inc. lifted its holdings in shares of Mesa Laboratories by 6.5% in the first quarter. Raymond James Financial Inc. now owns 264,013 shares of the medical instruments supplier’s stock valued at $31,328,000 after purchasing an additional 16,218 shares in the last quarter. Principal Financial Group Inc. boosted its position in shares of Mesa Laboratories by 13.8% during the first quarter. Principal Financial Group Inc. now owns 43,659 shares of the medical instruments supplier’s stock valued at $5,181,000 after buying an additional 5,300 shares during the last quarter. Finally, Herald Investment Management Ltd boosted its position in shares of Mesa Laboratories by 68.5% during the first quarter. Herald Investment Management Ltd now owns 12,500 shares of the medical instruments supplier’s stock valued at $1,483,000 after buying an additional 5,083 shares during the last quarter. 90.60% of the stock is owned by institutional investors.

Mesa Laboratories Stock Up 1.3%

Mesa Laboratories stock opened at $77.91 on Wednesday. The firm has a 50 day moving average price of $69.28 and a 200-day moving average price of $87.21. The company has a quick ratio of 0.47, a current ratio of 0.66 and a debt-to-equity ratio of 0.46. Mesa Laboratories, Inc. has a twelve month low of $55.45 and a twelve month high of $155.12. The company has a market capitalization of $428.51 million, a P/E ratio of -556.50 and a beta of 0.86.

Mesa Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 15th. Shareholders of record on Friday, November 28th will be paid a $0.16 dividend. The ex-dividend date is Friday, November 28th. This represents a $0.64 annualized dividend and a dividend yield of 0.8%. Mesa Laboratories’s payout ratio is presently -457.14%.

Analyst Upgrades and Downgrades

A number of research firms recently commented on MLAB. Wall Street Zen lowered Mesa Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th. Weiss Ratings reiterated a “sell (d)” rating on shares of Mesa Laboratories in a report on Wednesday, October 8th. Zacks Research raised shares of Mesa Laboratories from a “strong sell” rating to a “hold” rating in a research report on Monday, August 18th. Finally, Wells Fargo & Company raised shares of Mesa Laboratories from an “underweight” rating to an “equal weight” rating and reduced their price objective for the stock from $100.00 to $67.00 in a research report on Thursday, August 7th. Two analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Reduce” and a consensus price target of $67.00.

Mesa Laboratories Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.